Russian authorities will provide access to subsidies for product certification for foreign markets to companies exporting medicines and medical products. Compensation can be up to 80% of the cost of registration abroad. The corresponding resolution was signed by Prime Minister Mikhail Mishustin.
According to the document, the maximum amount of reimbursement for drug manufacturers is 500 million rubles. for certification of one product. For other producers – 50 million rubles.
“The decision will reduce the costs of domestic pharmaceutical manufacturers when entering foreign markets, increase demand for Russian highly competitive products and stimulate the growth of non-primary exports,” the government website said.
The decree states that the recipient of the subsidy undertakes to export the registered product in an amount not less than 10 times the amount of state support. In the case of medicines, this must be done within five years after all the necessary permits have been obtained, in the case of medical products – within three years.
In 2021, 540 million rubles were provided for this support measure in the budget. For 2022 and 2023 – 2.47 billion and 4.32 billion, respectively.
